All Stories

  1. Safety of recombinant coagulation factors in treating hemophilia

    Article • Expert Opinion on Drug Safety, February 2019, Taylor & Francis

    Massimo Morfini

  2. Patient satisfaction and acceptability of an on-demand and on-prophylaxis device for factor VIII delivery in patients with hemophilia A

    Article • Patient Preference and Adherence, January 2019, Dove Medical Press

    Massimo Morfini, Dr Dorina Cultrera

  3. Pharmacokinetics and the transition to extended half-life factor concentrates: communication from the SSC of the ISTH

    Article • Journal of Thrombosis and Haemostasis, June 2018, Wiley

    Massimo Morfini, Professor Alfonso Iorio

  4. Pharmacokinetic-based prediction of real-life dosing of extended half-life clotting factor concentrates on hemophilia

    Article • Therapeutic Advances in Hematology, June 2018, SAGE Publications

    Massimo Morfini

  5. Performing and interpreting individual pharmacokinetic profiles in patients with Hemophilia A or B: Rationale and general considerations

    Article • Research and Practice in Thrombosis and Haemostasis, May 2018, Wiley

    Massimo Morfini, Professor Alfonso Iorio, Dr Ellis J Neufeld

  6. Outcome measures for adult and pediatric hemophilia patients with inhibitors

    Article • European Journal Of Haematology, April 2017, Wiley

    Massimo Morfini, Dr Victor Jimenez-Yuste

  7. Correlation between FIX genotype and pharmacokinetics of Nonacog alpha according to a multicentre Italian study

    Article • Haemophilia, March 2016, Wiley

    Massimo Morfini

  8. Rapid rFVIIa enhanced on-demand dosing in haemophilia inhibitor patients

    Article • European Journal Of Haematology, July 2015, Wiley

    Massimo Morfini

  9. Pharmacokinetics of plasma‐derived vs. recombinantFVIIIconcentrates: a comparative study

    Article • Haemophilia, October 2014, Wiley

    Massimo Morfini

  10. Innovative approach for improved rFVIII concentrate

    Article • European Journal Of Haematology, May 2014, Wiley

    Massimo Morfini

  11. Perceived challenges and attitudes to regimen and product selection from Italian haemophilia treaters: the 2013 AICE survey

    Article • Haemophilia, February 2014, Wiley

    Massimo Morfini